The North American Neuroendocrine Tumor Society (NANETS) was established as a non-profit organization whose primary purpose is to improve neuroendocrine tumor disease management through increased research and educational opportunities. To successfully accomplish this mission, NANETS recognizes that our corporate partners play a vital role.

Therefore, NANETS has created a Corporate Liaison Committee. The goals of this group are to institute effective methods for communicating with all levels of the NANETS membership and establishing mutually beneficial relationships between professional and allied members.

What is the Corporate Liaison Committee?

The Vice Chair of the Executive Committee is the Chair of the Corporate Liaison Committee (CLC). This committee is comprised of individuals (allied members) from corporate industry with an interest in the execution of the NANETS's mission and will serve in an advisory capacity to the Board of Directors. Only one representative from each company can be a CLC member and will serve for a period of three years. If for some reason the member cannot serve for the full term, the allied affiliate can appoint an alternate member.

The designated CLC member from each company may participate in the annual Board of Director meeting but shall have no voting power on subjects related to this committee. There is an annual financial commitment to join the CLC which has been established and voted on by the Board of Directors.

How to Become a Member?

If you would like to join or need additional information about the benefits to your company, please contact NANETS via email or call Kari Brendtro at 360-314-4112.

Founding Corporate Liaison Members